A detailed history of James J. Burns & Company, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, James J. Burns & Company, LLC holds 2,425 shares of MRNA stock, worth $133,908. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,425
Holding current value
$133,908
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$101.21 - $166.61 $245,434 - $404,029
2,425 New
2,425 $288,000
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $168,561 - $253,242
2,425 New
2,425 $241,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track James J. Burns & Company, LLC Portfolio

Follow James J. Burns & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James J. Burns & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on James J. Burns & Company, LLC with notifications on news.